KATY, Texas — A couple was attacked by their own son inside their Katy home over the weekend, Precinct 5 Constable Terry Allbritton said. Investigators say the adult male beat and strangled his ...

Black Friday deals are officially upon us. We've seen loads of great deals popping up around the Internet, including some serious discounts on headphones. The Beats Studio Pro set is available for a ...

We listen to music while working, commuting, traveling, cleaning, shopping, and so on, and we know you do too. So why not do it in style? The gorgeous Beats Studio Pro just got an insane 57 percent ...

Journal Editorial Report: Paul Gigot interviews Democratic Pollster Doug Schoen. New weight-loss drugs are working wonders, but they’re also out of many patients’ financial reach. Enrollees in ...

Nov 6 (Reuters) - Viatris (VTRS.O), opens new tab on Thursday beat Wall Street estimates for third-quarter results, driven by strong demand for its branded drugs in China and emerging markets, and ...

AstraZeneca Plc’s profit rose more than analysts anticipated last quarter, buoyed by demand for its blockbuster cancer and diabetes drugs. Earnings per share, excluding some items, climbed 14% to ...

AstraZeneca Plc's profit rose more than analysts anticipated last quarter, buoyed by demand for its blockbuster cancer and diabetes drugs. CEO Pascal Soriot joined Bloomberg's The Opening Trade to ...

Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay cystic fibrosis treatment saw revenue growth, even as new drugs’ ...

The U.S. drug maker reported revenues of $7.77 billion, beating the consensus of $7.45 billion. Product sales decreased 2% to $7.3 billion, primarily driven by lower Veklury (remdesivir) and Cell ...

More and more people are using weight-loss drugs, and it's costing employers big time. That is, if they even cover the medications in the first place. GLP-1 drugs were approved for weight-loss a few ...

Roche Holding said experimental drug giredestrant outperformed the standard-of-care treatment in a late-stage trial, showing significant improvements for breast-cancer patients. The Swiss pharma group ...

The popularity of GLP-1 drugs for weight loss continues to rise. About one in eight adults in the U.S. has tried medications like Ozempic or Mounjaro. Experts say how much you'll lose varies, and a ...